Psyence Biomedical Ltd. (PBM)Healthcare | Biotechnology | Toronto, Canada | NasdaqCM
4.21 USD
-0.10
(-2.320%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 4.21 |
Hot Take ↕ | Aug. 22, 2026, 3:18 a.m. EDT
The immediate outlook is neutral-to-slightly-bearish despite a recent pop; the stock is trading near its 50-day average after a sharp spike, but the underlying reality is a catastrophic multi-year collapse. Over the last three years, the asset has lost 99.95% of its value, driven by two consecutive years of massive declines (-95% and -99%), signaling a complete structural failure rather than a temporary dip. Fundamentals confirm this distress: the company is burning cash with negative operating and free cash flows, posting severe losses on assets and equity, and trading at less than 60% of its book value due to the market's verdict on its deteriorating business. There is no dividend to provide income, and the statistical forecasting models offer virtually no guidance given their extremely low reliability scores. While headlines mention a reverse stock split and potential policy tailwinds, these are speculative catalysts for a micro-cap with no earnings power, making a long-term hold untenable. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.262981 |
| AutoARIMA | 0.275468 |
| AutoETS | 0.275473 |
| AutoTheta | 0.439933 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 23% |
| H-stat | 2.32 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.073 |
| Excess Kurtosis | 0.51 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 16,058,321 |
| Beta | 1.67 |
| Previous Name | Psyence Therapeutics Corp. |
| Website | https://psyencebiomed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9608738 |
| Address1 | 121 Richmond Street West |
| Address2 | Penthouse Suite 1300 |
| All Time High | 341,015.62 |
| All Time Low | 1.92 |
| Ask | 5.44 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 147,180 |
| Average Daily Volume3 Month | 88,490 |
| Average Volume | 88,490 |
| Average Volume10Days | 147,180 |
| Beta | 1.668 |
| Bid | 3.11 |
| Bid Size | 2 |
| Book Value | 7.389 |
| City | Toronto |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.21 |
| Current Ratio | 14.619 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 4.37 |
| Day Low | 4.185 |
| Display Name | Psyence Biomedical |
| Ebitda | -6,232,245 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.382 |
| Enterprise Value | 8,613,558 |
| Eps Trailing Twelve Months | -12.56 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.2954 |
| Fifty Day Average Change | 0.91460013 |
| Fifty Day Average Change Percent | 0.27753845 |
| Fifty Two Week Change Percent | -96.08738 |
| Fifty Two Week High | 216.40625 |
| Fifty Two Week High Change | -212.19624 |
| Fifty Two Week High Change Percent | -0.9805458 |
| Fifty Two Week Low | 1.92 |
| Fifty Two Week Low Change | 2.29 |
| Fifty Two Week Low Change Percent | 1.1927084 |
| Fifty Two Week Range | 1.92 - 216.40625 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,639,146,600,000 |
| Float Shares | 2,607,742 |
| Free Cashflow | -4,955,898 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Fullday Change | -0.0999999 |
| Fullday Change Percent | -2.32018 |
| Fullday Price | 4.21 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0297 |
| Held Percent Institutions | 0.09717 |
| Implied Shares Outstanding | 3,814,328 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,024-01-26 |
| Language | en-US |
| Last Fiscal Year End | 1,774,915,200 |
| Last Split Date | 1,769,990,400 |
| Last Split Factor | 16:100 |
| Long Business Summary | Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc. |
| Long Name | Psyence Biomedical Ltd. |
| Market | us_market |
| Market Cap | 16,058,321 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_698500412 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -6,936,421 |
| Next Fiscal Year End | 1,806,451,200 |
| Non Diluted Market Cap | 16,439,753 |
| Open | 4.37 |
| Operating Cashflow | -8,143,007 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 416-477-1708 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 4.21 |
| Post Market Time | 1,787,960,964 |
| Prev Name | Psyence Therapeutics Corp. |
| Previous Close | 4.31 |
| Price Hint | 4 |
| Price To Book | 0.56976587 |
| Profit Margins | 0.0 |
| Quick Ratio | 12.122 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0999999 |
| Regular Market Change Percent | -2.32018 |
| Regular Market Day High | 4.37 |
| Regular Market Day Low | 4.185 |
| Regular Market Day Range | 4.185 - 4.37 |
| Regular Market Open | 4.37 |
| Regular Market Previous Close | 4.31 |
| Regular Market Price | 4.21 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 14,689 |
| Return On Assets | -0.31333 |
| Return On Equity | -0.58619 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,814,328 |
| Shares Percent Shares Out | 0.0038 |
| Shares Short | 14,380 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 30,720 |
| Short Name | Psyence Biomedical Ltd. |
| Short Percent Of Float | 0.0054 |
| Short Ratio | 0.15 |
| Source Interval | 15 |
| State | ON |
| Symbol | PBM |
| Total Cash | 7,444,763 |
| Total Cash Per Share | 1.952 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -12.56 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.310524 |
| Two Hundred Day Average Change | -12.100524 |
| Two Hundred Day Average Change Percent | -0.7418844 |
| Type Disp | Equity |
| Volume | 14,689 |
| Website | https://psyencebiomed.com |
| Zip | M5H 2K1 |